Biopharmaceuticals Startup Funding

Psilera Inc.

Location: Tampa, Florida, USA

Website: psilera.com

Funding: Closes Oversubscribed $8.8M

Date: 29 days ago

Psilera Inc. is a Tampa-based biopharmaceutical company pioneering next-generation neuroplastogen and psychedelic therapies, advancing its lead candidate PSIL-006 toward first-in-human trials in 2027 to address neurological disorders.

Compass Pathways

Location: -

Funding: Raised to $22.00

Date: 43 days ago

Compass Pathways is a biopharmaceutical company developing psilocybin-based therapies to treat patients with treatment-resistant depression, aiming to transform mental health care through novel psychedelic-assisted treatments.

BioCryst Pharmaceuticals

Location: -

Funding: Raised to $28.00

Date: 49 days ago

BioCryst Pharmaceuticals is a biopharmaceutical company specializing in the design and development of oral small-molecule therapies for rare diseases, leveraging structure-based drug design to address conditions such as hereditary angioedema.

Citius Oncology, Inc.

Location: Cranford, New Jersey

Funding: Secures Up to $36.5 M

Date: 51 days ago

Citius Oncology is a public biopharmaceutical company based in Cranford, New Jersey, focused on developing and commercializing innovative oncology therapies, including its lead product Lymphir.

Paradigm Biopharmaceuticals

Location: Sydney, Australia

Funding: raises $14M

Date: 60 days ago

Paradigm Biopharmaceuticals is an ASX-listed biopharmaceutical company developing regenerative therapies for osteoarthritis and other musculoskeletal conditions. Its proprietary small-molecule treatments aim to stimulate cartilage repair and bone regeneration to address degenerative joint disease and associated pain.

Satellos Bioscience

Location: -

Funding: Raised to $11.00

Date: 88 days ago

Satellos Bioscience is a biopharmaceutical company developing therapeutics that target DNA damage tolerance and repair pathways to treat cancer and age-related diseases using its proprietary genome integrity platform.

KalVista Pharmaceuticals

Location: -

Funding: Raised to $42.00

Date: 89 days ago

KalVista Pharmaceuticals is a clinical-stage biopharmaceutical company focused on discovering and developing oral small molecule protease inhibitors to treat rare diseases such as hereditary angioedema and ocular disorders including diabetic macular edema.

Ocugen

Location: -

Funding: Raised to $10.00

Date: 93 days ago

Ocugen is a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies and therapeutics to treat retinal and other ocular diseases, aiming to restore vision by addressing underlying genetic causes.

NewAmsterdam Pharma

Location: -

Funding: Raised to $48.00

Date: 125 days ago

NewAmsterdam Pharma is a clinical-stage biopharmaceutical company developing novel therapies for endocrine and metabolic disorders such as congenital hyperinsulinism and congenital adrenal hyperplasia.

Resverlogix Corp.

Location: Calgary, Alberta, Canada

Website: resverlogix.com

Funding: Closes $2.8 M

Date: 127 days ago

Resverlogix Corp is a clinical-stage biopharmaceutical company focused on developing epigenetic-based therapies to treat cardiovascular and other chronic diseases by targeting the regulation of gene expression.

Kainova Therapeutics

Location: Montréal, Canada

Website: kainovatx.com

Funding: closes $32 m

Date: 134 days ago

Kainova Therapeutics is a Montréal-based clinical-stage biopharmaceutical company developing novel cancer and inflammation therapies and advancing its pipeline through clinical trials.

Kainova Therapeutics

Location: Montreal, Canada

Website: kainovatx.com

Funding: Secures $32M

Date: 136 days ago

Kainova Therapeutics is a clinical-stage biopharmaceutical company developing breakthrough immuno-oncology and inflammation therapies aimed at delivering novel treatments for patients.

Pinwheel Therapeutics

Location: -

Funding: raises $20 m

Date: 139 days ago

Pinwheel Therapeutics is a clinical-stage biopharmaceutical company developing differentiated therapeutic assets and recently secured a $20 million growth equity investment from US-based 108 BioCapital to recapitalize a late-stage clinical asset.

Zelira Therapeutics

Location: Australia

Website: zeliratx.com

Funding: secures transformative US$33 m

Date: 161 days ago

Zelira Therapeutics is an ASX­-listed Australian biopharmaceutical company specializing in cannabis­-based and psychedelic-derived therapeutics, advancing clinical programs such as its HOPE­-1 autism treatment.

Immunovant

Location: -

Funding: Raised to $22.00

Date: 166 days ago

Immunovant is a clinical-stage biopharmaceutical company developing targeted therapies for autoimmune diseases by inhibiting the neonatal Fc receptor (FcRn) to reduce pathogenic antibodies.

Oculis

Location: -

Funding: Raised to $40.00

Date: 189 days ago

Oculis SA is a clinical-stage ophthalmic biopharmaceutical company developing novel therapies to treat acute and chronic eye diseases, including dry eye and retinal disorders.

Roivant Sciences

Location: -

Funding: Raised to $33.00

Date: 192 days ago

Roivant Sciences is a biopharmaceutical company that acquires, develops, and commercializes therapeutic assets through a network of subsidiary biotech companies, aiming to bring innovative treatments to market more efficiently.

Nurix Therapeutics

Location: -

Funding: Raised to $30.00

Date: 195 days ago

Nurix Therapeutics is a biopharmaceutical company developing targeted small-molecule therapies that harness the ubiquitin proteasome system to degrade disease-causing proteins in oncology and immunology.

Bristol Myers Squibb Company

Location: -

Funding: Raises Dividend to $0.63

Date: 197 days ago

Bristol Myers Squibb is a global biopharmaceutical company specializing in the research, development, and commercialization of prescription therapies for serious diseases, with a focus on oncology, immunology, and cardiovascular health.

OYE Therapeutics

Location: Crown Point, Indiana, USA

Website: oyetherapeutics.com

Funding: raises $5.6M

Date: 203 days ago

OYE Therapeutics is a biopharmaceutical company developing an intravenous caffeine-based therapy to reverse general anesthesia, sedation, and opioid-induced respiratory depression, currently advancing its lead candidate into clinical trials.

Ensysce Biosciences, Inc.

Location: San Diego, CA

Website: ensysce.com

Funding: Secures $4 M

Date: 221 days ago

Ensysce Biosciences is a clinical-stage biopharmaceutical company developing novel severe pain therapeutics with built-in abuse- and overdose-resistant features, such as PF614, to enhance patient safety while providing effective analgesia.

Adicet Bio

Location: -

Funding: Raised to $9.00

Date: 230 days ago

Adicet Bio is a clinical-stage biopharmaceutical company developing off-the-shelf allogeneic gamma delta T-cell therapies for oncology and other diseases, aiming to deliver scalable, immune cell–based treatments.

Exelixis

Location: -

Funding: Raised to $49.00

Date: 230 days ago

Exelixis is a biopharmaceutical company specializing in the discovery, development, and commercialization of small molecule therapies for the treatment of cancer.

Day One Biopharmaceuticals

Location: -

Funding: Raised to $26.00

Date: 230 days ago

Day One Biopharmaceuticals is a clinical-stage biopharmaceutical company developing targeted small molecule therapies for hematologic malignancies and solid tumors to improve patient outcomes.

Harmony Biosciences

Location: -

Funding: Raised to $39.00

Date: 230 days ago

Harmony Biosciences is a biopharmaceutical company focused on developing and commercializing therapies for sleep and neurological disorders, notably its lead product pitolisant (WAKIX) for treating excessive daytime sleepiness in narcolepsy.

Pelthos Therapeutics Inc.

Location: -

Funding: Raises $18 M

Date: 231 days ago

Pelthos Therapeutics Inc. is a biopharmaceutical company that acquires and commercializes antimicrobial therapies, including Xepi (ozenoxacin) cream for the topical treatment of impetigo caused by Staphylococcus aureus and Streptococcus pyogenes.

Ardelyx

Location: -

Funding: Raised to $10.00

Date: 231 days ago

Ardelyx is a biopharmaceutical company focused on developing and commercializing novel therapies for gastrointestinal and cardiorenal disorders, aiming to address unmet medical needs and improve patient outcomes.

ENA Respiratory

Location: Australia

Funding: Secures AU$34M

Date: 242 days ago

ENA Respiratory is a clinical-stage biopharmaceutical company developing antiviral drugs that enhance the body's natural defense against respiratory viruses to reduce the severity of symptomatic infections.

Innovent Biologics Inc.

Location: Hong Kong

Website: innoventbio.com

Funding: secures $11.4bn

Date: 245 days ago

Innovent Biologics Inc. is a Hong Kong–based biopharmaceutical company that researches, develops, and commercializes innovative biologic therapies, with a particular focus on oncology. It leverages strategic partnerships with global pharmaceutical firms to accelerate drug development and expand its pipeline.

PleoPharma, Inc.

Location: Phoenixville, Pa.

Website: pleopharma.com

Funding: Closes $36 M

Date: 248 days ago

PleoPharma, Inc. is a biopharmaceutical company developing treatments for cannabis-related health issues, advancing its lead asset PP-01 into Phase 3 clinical trials for patients with Cannabis Use Disorder.

Omnix Medical

Location: Jerusalem, Israel

Website: omnixmedical.com

Funding: Secures $25 M

Date: 254 days ago

Omnix Medical is a Jerusalem-based biopharmaceutical company developing novel, first-in-class antimicrobial therapies to overcome antibiotic resistance and address urgent global health threats.

Emergent BioSolutions Inc.

Location: Gaithersburg, Maryland, USA

Website: emergentbiosolutions.com

Funding: Secures $29 M

Date: 280 days ago

Emergent BioSolutions Inc. develops, manufactures and supplies medical countermeasures, including vaccines and therapeutics against biological threats such as smallpox, anthrax and botulism, to government and public health agencies worldwide.

Amylyx Pharmaceuticals

Location: -

Funding: Raised to $25.00

Date: 281 days ago

Amylyx Pharmaceuticals is a clinical-stage biopharmaceutical company developing therapies for neurodegenerative diseases, particularly amyotrophic lateral sclerosis (ALS). Its lead candidate AMX0035 targets cellular stress pathways to slow disease progression and improve patient outcomes.

Xenon Pharmaceuticals

Location: -

Funding: Raised to $43.00

Date: 315 days ago

Xenon Pharmaceuticals is a clinical-stage biopharmaceutical company developing novel small molecule therapies that modulate ion channels to treat neurological disorders, pain, and rare diseases.

Tryptamine

Location: Australia

Funding: secures $2.6 m

Date: 318 days ago

Tryptamine is an Australian clinical-stage biopharmaceutical company developing psilocin-based psychedelic therapies for neurological and psychiatric disorders.

Inosan Biopharma

Location: Unknown

Funding: close to $1m

Date: 400 days ago

Inosan Biopharma is a biopharmaceutical company that develops and manufactures antivenom therapies for snakebite envenomation, providing venom-neutralizing treatments for military and civilian applications.

Telomir Pharmaceuticals, Inc.

Location: -

Funding: Raise $3 M

Date: 401 days ago

Telomir Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing novel therapies for rare diseases. The company leverages strategic equity financing to advance its drug candidates through clinical development.

Avammune Therapeutics

Location: -

Funding: raises $12 m

Date: 410 days ago

Avammune Therapeutics is an early‐stage biopharmaceutical company developing novel small molecule immunotherapies to activate the innate immune system against cancer and autoimmune disorders; its lead ENPP1 inhibitor, AVA-NP-695, is advancing toward clinical trials after promising preclinical results.